Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schaller

Showing results (11-20 of 283) with videos related to

Pageof 29
Sort By:
The Journal of Dermatological Treatment|July 28, 2017
Long-term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilolKatharina Pietschke, Martin Schaller
Journal of the American Academy of Dermatology|November 16, 2013
Ocular rosacea: a dermatologic perspectiveGuy Webster, Martin Schaller
Drugs in R&D|September 15, 2016
A Tailored Approach to the Treatment of a Patient with a Severe Dynamic Manifestation of Rosacea: A Case ReportMartin Schaller, Lena Gonser
International Journal of Dermatology|December 21, 2002
Xanthoma disseminatumRudolf A Rupec, Martin Schaller
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2008
Introduction: host responsesMartin Schaller, Günther Weindl, Bernhard Hube
BMJ Case Reports|May 11, 2013
Unwanted baggageNicolas Leitz, Zarqa Leitz, Martin Schaller
Ocular Immunology and Inflammation|February 28, 2022
Rosacea and Dry Eye DiseaseBianka Sobolewska, Martin Schaller, Manfred Zierhut
The Journal of Clinical and Aesthetic Dermatology|August 9, 2022
How to Optimize Rosacea Treatment for Better Patient Outcomes: An Opinion PieceMartin Schaller, Jerry Tan, Guy Webster
International Journal of Medical Microbiology : IJMM|May 10, 2011
Interaction of the mucosal barrier with accessory immune cells during fungal infectionGünther Weindl, Jeanette Wagener, Martin Schaller
Mycoses|September 20, 2017
Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosisMartin Schaller, Bardur Sigurgeirsson, Marlis Sarkany
Pageof 29

Showing results (11-20 of 283) with videos related to

Sort By:
Pageof 29
The Journal of Dermatological Treatment|July 28, 2017
Long-term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilolKatharina Pietschke, Martin Schaller
Journal of the American Academy of Dermatology|November 16, 2013
Ocular rosacea: a dermatologic perspectiveGuy Webster, Martin Schaller
Drugs in R&D|September 15, 2016
A Tailored Approach to the Treatment of a Patient with a Severe Dynamic Manifestation of Rosacea: A Case ReportMartin Schaller, Lena Gonser
International Journal of Dermatology|December 21, 2002
Xanthoma disseminatumRudolf A Rupec, Martin Schaller
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2008
Introduction: host responsesMartin Schaller, Günther Weindl, Bernhard Hube
BMJ Case Reports|May 11, 2013
Unwanted baggageNicolas Leitz, Zarqa Leitz, Martin Schaller
Ocular Immunology and Inflammation|February 28, 2022
Rosacea and Dry Eye DiseaseBianka Sobolewska, Martin Schaller, Manfred Zierhut
The Journal of Clinical and Aesthetic Dermatology|August 9, 2022
How to Optimize Rosacea Treatment for Better Patient Outcomes: An Opinion PieceMartin Schaller, Jerry Tan, Guy Webster
International Journal of Medical Microbiology : IJMM|May 10, 2011
Interaction of the mucosal barrier with accessory immune cells during fungal infectionGünther Weindl, Jeanette Wagener, Martin Schaller
Mycoses|September 20, 2017
Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosisMartin Schaller, Bardur Sigurgeirsson, Marlis Sarkany
Pageof 29